Nova Mentis receives Health Canada approval for psilocybin clinical trial

Nova Mentis receives Health Canada approval for psilocybin clinical trial
VANCOUVER – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders  announced that the company has received a No Objection Letter from Health Canada, allowing NOVA to proceed with the first-ever Phase II A clinical trial assessing repetitive, oral microdose psilocybin therapy... Read More

Snowline Gold active on Yukon drilling news

Snowline Gold active on Yukon drilling news
VANCOUVER – Snowline Gold Corp. shares were active Thursday after the company released more preliminary assay results from drilling at the Valley Zone on its Rogue gold project in the Canadian Yukon. Drilling highlights include hole V-22-032 which intersected a zone of sheeted quartz vein mineralization within the Valley intrusion averaging 1.72 g/t gold over 207.0 metres within... Read More